| Autor: |
Pedro Valada, Sonja Hinz, Christin Vielmuth, Cátia R. Lopes, Rodrigo A. Cunha, Christa E. Müller, João Pedro Lopes |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Purinergic Signal |
| Popis: |
Inosine has robust neuroprotective effects, but it is unclear if inosine acts as direct ligand of adenosine receptors or if it triggers metabolic effects indirectly modifying the activity of adenosine receptors. We now combined radioligand binding studies with electrophysiological recordings in hippocampal slices to test how inosine controls synaptic transmission and plasticity. Inosine was without effect at 30 μM and decreased field excitatory post-synaptic potentials by 14% and 33% at 100 and 300 μM, respectively. These effects were prevented by the adenosine A(1) receptor antagonist DPCPX. Inosine at 300 (but not 100) μM also decreased the magnitude of long-term potentiation (LTP), an effect prevented by DPCPX and by the adenosine A(2A) receptor antagonist SCH58261. Inosine showed low affinity towards human and rat adenosine receptor subtypes with K(i) values of > 300 µM; only at the human and rat A(1) receptor slightly higher affinities with K(i) values of around 100 µM were observed. Affinity of inosine at the rat A(3) receptor was higher (K(i) of 1.37 µM), while it showed no interaction with the human orthologue. Notably, the effects of inosine on synaptic transmission and plasticity were abrogated by adenosine deaminase and by inhibiting equilibrative nucleoside transporters (ENT) with dipyridamole and NBTI. This shows that the impact of inosine on hippocampal synaptic transmission and plasticity is not due to a direct activation of adenosine receptors but is instead due to an indirect modification of the tonic activation of these adenosine receptors through an ENT-mediated modification of the extracellular levels of adenosine. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
